EUVIMEDEUVIMED entdecken
Crossref

Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis

Akash Mukherjee, Cesar Gentille, Asmita Patel, Joe Ensor, Lawrence Rice

International Journal of Hematology · 2024

DOI: 10.1007/s12185-024-03811-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Akash Mukherjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA. Hauptthemen laut MEDLINE: Heparin, Thrombocytopenia, Thrombosis, Platelet Factor 4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by platelet-activating antibodies targeting platelet factor 4 (PF4) and heparin complex. A higher antibody titer is reflected in a higher optical density (OD) by enzyme-linked immunosorbent assay for heparin-PF4 antibodies. This single-institution retrospective study of 116 HIT patients examined the effect of heparin-PF4 OD on time to platelet recovery, vascular thrombosis, and in-hospital mortality. Patients were divided into 3 cohorts based on heparin-PF4 OD: cohort 1 had an OD ≥ 2 and ≤ 2.4, cohort 2 had an OD > 2.4 and ≤ 2.8, and cohort 3 had an OD > 2.8. A higher OD titer was associated with significantly increased time to platelet recovery when compared between cohorts 1 versus 2 (HR = 0.599, p = 0.0221) and 1 versus 3 (HR = 0.515, p = 0.0014), as well as an increased risk of thrombosis (79.4%-cohort 3 vs 53.8%-cohort 2 vs 46.1%-cohort 1, p = 0.04), but had no impact on mortality (2.62-alive vs 2.65-deceased, p = 0.7432). A higher OD titer can inform risk assessment and support decision-making in HIT patients; however, prospective studies are needed to further clarify the impact of heparin-PF4 OD on outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinThrombocytopeniaThrombosisPlatelet Factor 4HumansMaleRetrospective StudiesFemaleMiddle AgedAgedBlood PlateletsAged, 80 and overAdultRisk FactorsAutoantibodiesPlatelet CountAntibodiesHospital Mortality

Stichwörter der Autor:innen

HITHeparin–PF4 antibodiesPlatelet recovery timeThrombosis

Substanzen

HeparinPlatelet Factor 4PF4 protein, humanAutoantibodiesAntibodies

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA.
  • Department of Hematology and Oncology, Houston Methodist Hospital, Houston, TX, USA. cggentille@gmail.com.
  • Department of Hematology and Oncology, Global Cancer Research Institute, San Jose, CA, USA.

Zitieren

APA

Mukherjee, A., Gentille, C., Patel, A., Ensor, J., & Rice, L. (2024). Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03811-2

Vancouver

Mukherjee A, Gentille C, Patel A, Ensor J, Rice L. Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03811-2

BibTeX
@article{Mukherjee2024,
  author = {Mukherjee, Akash and Gentille, Cesar and Patel, Asmita and Ensor, Joe and Rice, Lawrence},
  title = {Heparin-induced thrombocytopenia with very high antibody titer is associated with slower platelet recovery and higher risk of thrombosis},
  journal = {International Journal of Hematology},
  year = {2024},
  doi = {10.1007/s12185-024-03811-2}
}
Kostenlos starten →